Vesalius Cardiovascular Inc

Vesalius Cardiovascular is a Canadian medical device company founded in 2016 in Vancouver, Canada. The company specializes in designing and developing biomedical devices for the treatment of cardiovascular disease, specifically mitral valve regurgitation (MR). We are clinical. Our devices is introduced percutaneously (transfemoral/transseptal) to the heart, eliminating the need for open heart surgery and the related risks. The procedure can be performed by a Cardiovascular Interventionalist (Cardiologist or Cardiac Surgeon). Vesalius Cardiovascular is the result of several years of intensive private research and investigation, and advanced biomedical engineering. The inventor behind Vesalius Cardiovascular is Dr. Peter Skarsgard, a Vancouver-based Cardiac Surgeon, and Head of the Division of Cardiovascular Surgery at Vancouver General Hospital. Vesalius Cardiovascular has developed a biomedical device that can be introduced percutaneously (transfemoral/transseptal) to the heart, for the treatment of Degenerative MR (DMR). The principles of surgical mitral valve repair are utilized, but sternotomy, heart-lung bypass, and cardiac arrest - components of an open heart operation - are not required.